Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of HB0239  100th General Assembly


Short Description:  DRUG MANUFACTURER-DISCLOSURES

House Sponsors
Rep. Mary E. Flowers - Emanuel Chris Welch, Silvana Tabares, Thaddeus Jones, Camille Y. Lilly and Natalie A. Manley

Last Action
DateChamber Action
  3/31/2017HouseRule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance
410 ILCS 620/16.2 new
410 ILCS 620/16.3 new


Synopsis As Introduced
Amends the Illinois Food, Drug and Cosmetic Act. Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3 days after approval by the U.S. Food and Drug Administration. Provides that within 30 days after such notifications, prescription drug manufacturers shall report specified information to State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly. Provides that failure to report such information shall result in a specified civil penalty. Requires the General Assembly to conduct an annual public hearing on aggregate trends in prescription drug pricing. Provides that if the manufacturer of a prescription drug or its agent meets or otherwise communicates with a prescriber for the purpose of marketing a drug, then the manufacturer or its agent shall disclose to the prescriber if any ingredient in the drug it is marketing is known to pose a risk of dependency in humans. Makes other changes.

Actions 
DateChamber Action
  12/15/2016HousePrefiled with Clerk by Rep. Mary E. Flowers
  1/11/2017HouseFirst Reading
  1/11/2017HouseReferred to Rules Committee
  1/25/2017HouseAssigned to Health Care Licenses Committee
  1/31/2017HouseAdded Co-Sponsor Rep. Silvana Tabares
  1/31/2017HouseAdded Co-Sponsor Rep. Thaddeus Jones
  2/23/2017HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  2/28/2017HouseAdded Chief Co-Sponsor Rep. Emanuel Chris Welch
  3/14/2017HouseAdded Co-Sponsor Rep. Natalie A. Manley
  3/31/2017HouseRule 19(a) / Re-referred to Rules Committee

Back To Top